The Doris Duke Charitable Foundation has announced the recipients of its 2017 Clinical Scientist Development Awards.

The program provides funding to physician-scientists who are one to five years into their first faculty appointment and ready to transition to an independent research career. Engaged in a broad range of areas, from the role of epigenetics in healing in diabetes to novel treatments for insomnia, the awardees will receive $495,000 each over three years to conduct research and establish a laboratory.

This year also marks the twentieth anniversary of the awards. In honor of the late Harry B. Demopoulos, a DDCF trustee, the foundation is referring to the 2017 awards as the Dr. Harry B. Demopoulos Clinical Scientist Development Awards.

"We are continually impressed by the high caliber of the Clinical Scientist Development Awardees, their research, and the potential of that research to improve their patients' lives," said DDCF program director for medical research Betsy Myers. "At this crucial stage in their careers, we are proud to support them in balancing research and clinical responsibilities. We look forward to seeing both how their careers develop over the long term and their research contributes to improvements in human health."

For a complete list of the awardees, see the DDCF website.